Survey of intrauterine red blood cell (RBC) transfusion practices in the United States. Issue 12 (4th October 2022)

• Record Type: Journal Article
• Authors: Bakhtary, Sara; Panchalee, Tachjaree; Crowe, Elizabeth P.; Schwab, Marisa E.; Zakieh, Abdulhafiz; Josephson, Cassandra D.; Sobhani, Nasim C.; Gonzalez‐Velez, Juan M.; Goel, Ruchika
• Is Part Of: Transfusion. Volume 62:Issue 12(2022)
• Page Start: 2449
• Page End: 2453
• Publication Date: 2022-10-04
• Subjects: Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.17134
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Background: A paucity of data exists about the current practice of fetal red blood cell (RBC) transfusion in the United States (US). This investigation describes intrauterine transfusion (IUT) RBC product selection and processing practices at different US institutions. Methods: A transfusion medicine and maternal‐fetal medicine (MFM) team designed a survey to interrogate and characterize RBCs utilized for IUT. This survey was distributed to seventy US institutions with fetal treatment centers (October 2020–April 2021) identified through the NAFTNet (North American Fetal Therapy Network). Results: Thirty‐seven institutions responded (response rate 53%, 37/70), but five were excluded for not performing IUTs. Most (84%; 27/32) performed 1–24 IUTs annually; two performed >50 IUTs/year. Group O, Rh(D) negative RBC units were always used by 66% (21/32), and 75% (24/32) provided hemoconcentrated RBCs by washing (17/24) or dry packing (6/24). Overall, 66% (21/32) targeted a hematocrit ≥75%. Fifty percent provided both leukocyte‐reduced and CMV‐negative RBC units. Irradiation of RBC units was performed within 6 h of issue at 63% (20/32) of sites. Most (81%, 26/32) used RBC units at <7 days of age after collection, 56% (18/32) always provided washed RBC units, while 19% (6/32) issued washed RBC only if fresh units are unavailable. Implicated maternal RBC alloantibodies were matched for 78% (25/32) of the time. The transfused volume was universally determined by the MFMs. Discussion: Heterogeneity and lack of standardization exist in RBC product selection and special processing steps for IUTs in the US. Hence, the establishment of a consensus to standardize IUT protocols is needed.